Menu
About us
Overview
Our story
Our people
Charities
Our portfolio
Overview
Gene Therapy
Overview
Freeline
Gyroscope
SwanBio
Cell Therapy
Overview
Autolus
Achilles Therapeutics
Quell
Resolution
Small molecule
Overview
OMass therapeutics
Azeria Therapeutics
Biologics
Overview
Anaveon
Previous portfolio companies
Overview
Nightstar
Blue Earth
News and insights
Investors
Overview
Share price centre
RNS and inside information
Results centre
Financial calendar
Document library
Contact
Syncona FY20: Martin Murphy discusses the outlook for Syncona
Back to News and insights
Share this page
Martin Murphy - CEO
Published 11 Jun 2020
Play
Share this page:
Facebook
Twitter
Linkedin
Follow us on:
